Piperacetazine
An antipsychotic medication
Piperacetazine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Piperacetazine is a typical antipsychotic medication belonging to the class of phenothiazines. It is primarily used in the treatment of schizophrenia and other psychotic disorders. Piperacetazine works by blocking dopamine receptors in the brain, which helps to reduce symptoms such as hallucinations and delusions.
Pharmacology[edit | edit source]
Piperacetazine is a member of the phenothiazine class of antipsychotics, which are known for their dopamine antagonist properties. These medications are effective in managing symptoms of psychosis by inhibiting the action of dopamine, a neurotransmitter that is often found in excess in individuals with schizophrenia.
Mechanism of Action[edit | edit source]
The primary mechanism of action of piperacetazine involves the blockade of dopamine D2 receptors in the central nervous system. This action reduces the overactivity of dopamine pathways, which is thought to be a contributing factor in the development of psychotic symptoms.
Side Effects[edit | edit source]
Like other typical antipsychotics, piperacetazine can cause a range of side effects. Common side effects include sedation, dry mouth, constipation, and blurred vision. More serious side effects may include extrapyramidal symptoms such as tardive dyskinesia, which involves involuntary movements, and neuroleptic malignant syndrome, a rare but life-threatening condition.
Usage[edit | edit source]
Piperacetazine is administered orally and the dosage is typically adjusted based on the patient's response and the severity of symptoms. It is important for patients to follow their healthcare provider's instructions closely to minimize the risk of side effects and to achieve the best therapeutic outcome.
History[edit | edit source]
Piperacetazine was developed in the mid-20th century as part of the effort to find effective treatments for schizophrenia and other psychotic disorders. It was one of several phenothiazine derivatives that were synthesized and tested for antipsychotic activity.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD